All News

How pharmacists can help fight the battle.

The New Drug Review for April

Cardiac Matters-What you need to know about anakinra

Special pill bottle caps can help reduce medication misuse and abuse.

How Trinity Health and Pacira are minimizing opioid use.

The citizens petition process is being used to delay approval of generic drugs.

How physicians made millions and fed the opioid epidemic.

New legislation could be a model for other states.

The chain has said it remains committed to buying Rite Aid stores.

A reporter earned the biggest journalism prize covering the opioid crisis.

Supervalu’s diabetes campaign offers risk assessments, screening, and food education.

New class of glucose-lowering agents lowers hospitalization and death rates even in Type 2 patients without heart disease.

Trump and Gottlieb are both taking steps to end the opioid epidemic. But is it enough?

Small Doses is news for pharmacists in a way that works for you.

What the new company will mean for specialty pharmacy.

Why a drug that costs $65,000 a year is making patient groups happy.

Nearly 600,000 inhalers are being recalled.

Two previous reports of device failures lead EpiPen maker to expand recall to the United States.

What we know-and what we don't-about antibiotics in America.

Even medical marijuana has health-care costs and outcomes.

How a program hopes to cut errors in half.

Ontario joins Nova Scotia in making medication dispensing error reporting mandatory, but no states have enacted similar laws.

Taking a clear-eyed look at the cost of health care can reduce waste.

Biosimilars, cancer drugs, and orphan drugs are heading towards FDA approval in 2017.

What New York City is doing to curb the opioid epidemic.

This year's meeting highlighted the opioid epidemic and ways pharmacists can improve patient care.

This week, take a look at studies and news on supplements, depression, opioids, and more. Small doses is the news you need in a way that works for you.